884 results on '"Vehreschild, Maria"'
Search Results
2. Flucloxacillin and cefazolin for treatment of Staphylococcus aureus bloodstream infection
3. Comparison of post-COVID-19 symptoms in patients infected with the SARS-CoV-2 variants delta and omicron—results of the Cross-Sectoral Platform of the German National Pandemic Cohort Network (NAPKON-SUEP)
4. Coinfections and antimicrobial treatment in a cohort of falciparum malaria in a non-endemic country: a 10-year experience
5. Antibiotika, Antibiotikaprophylaxe und Antimykotika in der Intensivmedizin
6. A precise performance-based reimbursement model for the multi-centre NAPKON cohorts – development and evaluation
7. Differential radiological features of patients infected or colonised with slow-growing non-tuberculous mycobacteria
8. Antibiotics-Induced Intestinal Immunomodulation Attenuates Experimental Autoimmune Neuritis (EAN)
9. Kinetics of SARS-CoV-2 infection biomarkers in a household transmission study
10. Analysis of acute COVID-19 including chronic morbidity: protocol for the deep phenotyping National Pandemic Cohort Network in Germany (NAPKON-HAP)
11. Cytokine-responsive T- and NK-cells portray SARS-CoV-2 vaccine-responders and infection in multiple myeloma patients
12. Trends in the epidemiology of Clostridioides difficile infection in Germany
13. Real-world experience with letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation: A multi-centre observational study
14. Covid-19 triage in the emergency department 2.0: how analytics and AI transform a human-made algorithm for the prediction of clinical pathways
15. Specialized palliative care for hospitalized patients with SARS-CoV-2 infection: an analysis of the LEOSS registry
16. Use and effectiveness of remdesivir for the treatment of patients with covid-19 using data from the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS): a multicentre cohort study
17. Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022
18. Prevalence of infectious diseases, immunity to vaccine-preventable diseases and chronic medical conditions among Ukrainian refugees in Germany – A cross sectional study from the German Network University Medicine (NUM)
19. TIGIT+ NK cells in combination with specific gut microbiota features predict response to checkpoint inhibitor therapy in melanoma patients
20. Bacillus velezensis DSM 33864 reduces Clostridioides difficile colonization without disturbing commensal gut microbiota composition
21. Resolving colistin resistance and heteroresistance in Enterobacter species
22. Diarrhö unter Immunsuppression
23. Occurrence of extrapulmonary tuberculosis is associated with geographical origin: spatial characteristics of the Frankfurt TB cohort 2013–2018
24. Regulatory workshop on challenge strain development and GMP manufacture – A stakeholder meeting report
25. Short-term predictor for COVID-19 severity from a longitudinal multi-omics study for practical application in intensive care units
26. Comparative effectiveness of vancomycin and metronidazole on event-free survival after initial infection in patients with Clostridioides difficile—a German multicentre cohort study
27. Combined analysis of gut microbiota, diet and PNPLA3 polymorphism in biopsy‐proven non‐alcoholic fatty liver disease
28. Pyrimidine de novo synthesis inhibition selectively blocks effector but not memory T cell development
29. SARS-CoV-2 infection in chronic kidney disease patients with pre-existing dialysis: description across different pandemic intervals and effect on disease course (mortality)
30. Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial
31. Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings
32. The KINETIC phase 2 randomized controlled trial of oral pamapimod-pioglitazone in non-critically ill COVID-19 inpatients
33. Pooled allogeneic faecal microbiota MaaT013 for steroid-resistant gastrointestinal acute graft-versus-host disease: a single-arm, multicentre phase 2 trial
34. Clinical characteristics and outcome of Mycobacterium chimaera infections after cardiac surgery: systematic review and meta-analysis of 180 heater-cooler unit-associated cases
35. Redefining Clostridioides difficile infection antibiotic response and clinical outcomes
36. Antibiotika, Antibiotikaprophylaxe und Antimykotika in der Intensivmedizin
37. Safety and Efficacy of Vidofludimus Calcium in Patients Hospitalized with COVID-19: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial
38. Long-term cardiac pathology in individuals with mild initial COVID-19 illness
39. Rolle des Darmmikrobioms bei der Entstehung und Weitergabe von Antibiotikaresistenzen
40. Incidence of infection with multidrug-resistant Gram-negative bacteria and vancomycin-resistant enterococci in carriers: a systematic review and meta-regression analysis
41. Vancomycin-resistant Enterococcus faecium: admission prevalence, sequence types and risk factors–a cross-sectional study in seven German university hospitals from 2014 to 2018
42. Arzneimittelnutzung unter Pandemiebedingungen
43. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
44. Entwicklung und Validierung potenzieller Strukturindikatoren zur Evaluierung des klinisch-infektiologischen Versorgungsangebots in deutschen Krankenhäusern während der COVID-19-Pandemie
45. #395 Gut dysbiosis in ADPKD patients: a controlled pilot study
46. Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022
47. All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort
48. Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey
49. Development and validation of BLOOMY prediction scores for 14-day and 6-month mortality in hospitalised adults with bloodstream infections: a multicentre, prospective, cohort study
50. Potential of FX06 to prevent disease progression in hospitalized non-intubated COVID-19 patients — the randomized, EU-wide, placebo-controlled, phase II study design of IXION
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.